Aura Biosciences, Inc. (AURA) KPIs and segments

AURANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 6/30

$7.11−0.50 (-6.57%)

Close on Nov 12, 2026Market cap $737.34MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Aura Biosciences's business

Coming soon

This tab will track the numbers specific to Aura Biosciences's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?